Skip to content

Clinical Study on Acupuncture Acupoint Electrical Stimulation in Percutaneous Vertebroplasty

Clinical Study on Acupuncture Acupoint Electrical Stimulation in Percutaneous Vertebroplasty

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025001047
Enrollment
Unknown
Registered
2025-05-26
Start date
2025-06-01
Completion date
Unknown
Last updated
2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perioperative pain

Interventions

OFA group:Local anesthesia+electical acupuncture acupoint stimulation
Sufentanil group:Local anesthesia+Sufentanil

Sponsors

Xiangyang Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Age between 60-80 years old;Inclusion criteria: 2: ASA status I -? 3:undergoing percutaneous kyphoplasty under local anesthesia

Exclusion criteria

Exclusion criteria: 1: individuals with a history of neurological and psychiatric disorders such as schizophrenia depression etc. who areunable to communicate 2:ndividuals with opioid dependence and frequent use of painkillers. 3:Previous history of cerebral infarction and cerebral hemorrhage 4: History of myocardial infarction or severe coronary heart disease (stenosis degree>80%) that cannot tolerate Pkpsurgery uncontrolled hypertension; Patients with implanted pacemakers; 5:Pathological spinal compression fractures (such as bone tumors etc.) 6: Patients who feel dizzy or cannot tolerate acupuncture 7:Participated in other clinical studies within the past 3 months of enrollment. 8: refuse to participate.

Design outcomes

Primary

MeasureTime frame
postoperative fatigue;weighted NRS at 6, 24, 48 hours after surgery, and on postoperative day 30;intraopeative average NRS score;15-item quality of recovery;

Secondary

MeasureTime frame
The levels ofthe expression levels of inflammatory factors IL-10 within 24 hours after surgery;The contents of leukocytes lymphocytes and neutrophils in peripheral blood;The levels of a7nAChR receptors within 24 hours after surgery;The levels ofthe expression levels of inflammatory factors TNF-a within 24 hours after surgery;The levels of the expression levels of inflammatory factors IL-1ß within 24 hours after surgery;Intraoperative sufentanil dosage;

Countries

China

Contacts

Public ContactXingrui Gong

Xiangyang Central Hospital

gongxrhbxy@sohu.com15071551981

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026